From: Mature results of a randomized trial comparing two fractionation schedules of high dose rate endoluminal brachytherapy for the treatment of endobronchial tumors
Group I (4 × 3.8 Gy)
Group II (2 × 7.2 Gy)
(n = 60)
(n = 82)
Complete Response
4.1%
4.5%
Partial Response
44.9%
47.8%
No Change
8.2%
17.9%
Tumor Progression
42.9%
29.9%